124 related articles for article (PubMed ID: 31336440)
21. Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus.
Werzowa J; Pacini G; Hecking M; Fidler C; Haidinger M; Brath H; Thomas A; Säemann MD; Tura A
J Diabetes Complications; 2015; 29(8):1211-6. PubMed ID: 26264400
[TBL] [Abstract][Full Text] [Related]
22. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
23. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009.
de Beaufort CE; Lange K; Swift PG; Aman J; Cameron F; Castano L; Dorchy H; Fisher LK; Hoey H; Kaprio E; Kocova M; Neu A; Njolstad PR; Phillip M; Schoenle E; Robert JJ; Urukami T; Vanelli M; Danne T; Barrett T; Chiarelli F; Aanstoot HJ; Mortensen HB;
Pediatr Diabetes; 2013 Sep; 14(6):422-8. PubMed ID: 22957743
[TBL] [Abstract][Full Text] [Related]
24. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial.
Wishah RA; Al-Khawaldeh OA; Albsoul AM
Diabetes Metab Syndr; 2015; 9(4):271-6. PubMed ID: 25301007
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of HBA(1c) and postprandial glycemia during a standard breakfast test in patients with type 2 diabetes mellitus receiving glibenclamide].
Dreval' AV; Cheporeva ON; Red'kin IuA; Misnikova IV
Ter Arkh; 2010; 82(8):41-4. PubMed ID: 20873244
[TBL] [Abstract][Full Text] [Related]
26. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.
Tuttle KR; Lakshmanan MC; Rayner B; Busch RS; Zimmermann AG; Woodward DB; Botros FT
Lancet Diabetes Endocrinol; 2018 Aug; 6(8):605-617. PubMed ID: 29910024
[TBL] [Abstract][Full Text] [Related]
27. A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes.
Anjana RM; Kesavadev J; Neeta D; Tiwaskar M; Pradeepa R; Jebarani S; Thangamani S; Sastry NG; Brijendra Kumar S; Ramu M; Gupta PPK; Vignesh J; Chandru S; Kayalvizhi S; Jagdish PS; Uthra SCB; Lovelena M; Jyoti S; Suguna Priya S; Kannan A; Mohan V; Unnikrishnan R
Diabetes Technol Ther; 2017 Sep; 19(9):533-540. PubMed ID: 28930495
[TBL] [Abstract][Full Text] [Related]
28. Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea.
Khaloo P; Asadi Komeleh S; Alemi H; Mansournia MA; Mohammadi A; Yadegar A; Afarideh M; Esteghamati S; Nakhjavani M; Esteghamati A
J Endocrinol Invest; 2019 Jul; 42(7):851-857. PubMed ID: 30535871
[TBL] [Abstract][Full Text] [Related]
29. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.
Deshmukh H; Wilmot EG; Gregory R; Barnes D; Narendran P; Saunders S; Furlong N; Kamaruddin S; Banatwalla R; Herring R; Kilvert A; Patmore J; Walton C; Ryder REJ; Sathyapalan T
Diabetes Care; 2020 Sep; 43(9):2153-2160. PubMed ID: 32669277
[TBL] [Abstract][Full Text] [Related]
30. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control.
Shalitin S; Fisher S; Yackbovitch-Gavan M; de Vries L; Lazar L; Lebenthal Y; Phillip M
Pediatr Diabetes; 2018 Mar; 19(2):320-328. PubMed ID: 28568379
[TBL] [Abstract][Full Text] [Related]
31. Effect of glycemic gap upon mortality in critically ill patients with diabetes.
Lou R; Jiang L; Zhu B
J Diabetes Investig; 2021 Dec; 12(12):2212-2220. PubMed ID: 34075715
[TBL] [Abstract][Full Text] [Related]
32. Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study.
Kuroda N; Kusunoki Y; Osugi K; Ohigashi M; Azuma D; Ikeda H; Makino S; Otsuka A; Tamada D; Watanabe N; Washio K; Tsunoda T; Matsuo T; Konishi K; Katsuno T; Koyama H;
J Diabetes Investig; 2021 Feb; 12(2):244-253. PubMed ID: 32594655
[TBL] [Abstract][Full Text] [Related]
33. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
[TBL] [Abstract][Full Text] [Related]
34. Concordance the hemoglobin glycation index with glycation gap using glycated albumin in patients with type 2 diabetes.
Kim MK; Jeong JS; Kwon HS; Baek KH; Song KH
J Diabetes Complications; 2017 Jul; 31(7):1127-1131. PubMed ID: 28487124
[TBL] [Abstract][Full Text] [Related]
35. Clinical Application of the Food Insulin Index for Mealtime Insulin Dosing in Adults with Type 1 Diabetes: A Randomized Controlled Trial.
Bell KJ; Gray R; Munns D; Petocz P; Steil G; Howard G; Colagiuri S; Brand-Miller JC
Diabetes Technol Ther; 2016 Apr; 18(4):218-25. PubMed ID: 26840067
[TBL] [Abstract][Full Text] [Related]
36. Dulaglutide-combined basal plus correction insulin therapy contributes to ideal glycemic control in non-critical hospitalized patients.
Fushimi N; Shibuya T; Yoshida Y; Ito S; Hachiya H; Mori A
J Diabetes Investig; 2020 Jan; 11(1):125-131. PubMed ID: 31168938
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal-L-C randomized trial.
Yang W; Min K; Zhou Z; Li L; Xu X; Zhu D; Venkateshwar Rao A; Murthy LS; Zhang N; Li I; Niemoeller E; Shang S
Diabetes Obes Metab; 2018 Feb; 20(2):335-343. PubMed ID: 28742225
[TBL] [Abstract][Full Text] [Related]
38. Adherence to Guidelines for Inpatient Pharmacologic Management of Type 2 Diabetes in Adults and Glycemic Outcomes.
Alkhiari R; Alzayer H; Aljazeeri J; Vanniyasingam T; Punthakee Z
Can J Diabetes; 2018 Apr; 42(2):158-162. PubMed ID: 28662968
[TBL] [Abstract][Full Text] [Related]
39. Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes.
Yamada E; Okada S; Nakajima Y; Bastie C; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
J Diabetes; 2018 Feb; 10(2):140-147. PubMed ID: 28544548
[TBL] [Abstract][Full Text] [Related]
40. Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c.
Gallwitz B; Dagogo-Jack S; Thieu V; Garcia-Perez LE; Pavo I; Yu M; Robertson KE; Zhang N; Giorgino F
Diabetes Obes Metab; 2018 Feb; 20(2):409-418. PubMed ID: 28817231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
